Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New Mexico for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New Mexico only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New Mexico (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Annette Fontaine (NPI 1346234788)

Field	Value
Entity Type	Individual
Organization	Annette Fontaine
Address	4901 Lang Ave Ne
City	Albuquerque
State	NM
ZIP	87109
Taxonomy	Medical Oncology Physician
NPI Enumerated	August 31, 2005

Payer Source	Total Paid
Medicare	$918.5K
Medicaid	$0

Key Findings

This provider’s Medicare footprint is the sole payer presence on file: total Medicare revenue is $918.5K and there is no Medicaid billing on file. In practical terms this makes the practice effectively single‑payer (Medicare) for the claim data available, concentrating revenue and regulatory exposure on the Medicare program.

Revenue is highly concentrated in three codes: the precomputed top 3 codes account for 75.0% of Medicare revenue, led by J9271 ($361.2K, 40.1%), followed by J0897 ($237.6K, 26.4%), and 99215 ($76.3K, 8.5%). These three codes together drive the majority of billed Medicare dollars and define the commercial profile of the practice.

The code mix points to an oncology infusion and complex outpatient management operation: J9271 (pembrolizumab) and J0897 (denosumab) are the largest revenue drivers by dollar value, supported by chemotherapy administration codes such as 96413 ($25.2K, 2.8%) and 96401 ($10.2K, 1.1%). The significant revenue from 99215 visits ($76.3K) indicates frequent high‑complexity E/M encounters consistent with ongoing, active oncology management of established patients.

Competitive standing for the highest‑value drug lines is mixed when compared to national peers. J9271 ranks #1358 of 1841 providers nationally (25th percentile), characterized as typical, unremarkable volume for this code, while J0897 ranks #691 of 10057 providers nationally (93th percentile) — a rank that the peer data labels as typical, unremarkable volume despite its high percentile position.

By contrast, evaluation/management work is a pronounced outlier: 99215 ranks #1249 of 145531 providers nationally (99th percentile) and is described as an "extreme outlier, far above typical national volume for this code." This indicates unusually large billing or visit intensity for high‑complexity established‑patient office encounters relative to the Medicare workforce.

Claim counts underline operational scale in infusion services: J0897 shows 13.2K claims and J9271 shows 8.4K claims, together representing the bulk of procedural encounter volume tied to high‑dollar drug administration. Those volumes, paired with multiple chemotherapy administration codes (96413, 96401, 96402), are consistent with an established infusion practice rather than a pure consultative or surgical oncology role.

The practice also bills for adjunctive oncology and supportive therapies — for example, J1569 (immune globulin) appears with $42.5K in revenue (4.7%) and G6015 (IMRT delivery) contributes $8.7K (1.0%). Presence of both systemic therapy administration and radiation‑related planning/treatment codes suggests a multimodal service mix or coordinated referrals within oncology care pathways.

This provider has a long tenure in the registry, with NPI enumeration on 2005-08-31 (~21 years ago), aligning with the observed sustained patterns of infusion and complex office management. The combination of long tenure, heavy dependence on a few high‑value codes, and an extreme outlier position for 99215 should shape payer and partner conversations about care pathways, utilization patterns, and oversight focused on high‑intensity outpatient oncology management.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

45 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	8,400	$40	$361.2K
J0897	Injection, denosumab, 1 mg	13,200	$20	$237.6K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	590	$130	$76.3K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	1,180	$40	$42.5K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	260	$100	$25.2K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	180	$130	$23.8K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	11,380	$1	$22.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	230	$90	$21.1K
J1439	Injection, ferric carboxymaltose, 1 mg	18,750	$1	$18.8K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	190	$50	$10.2K

Showing 1–10 of 45

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 45 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New Mexico Distribution

Annette Fontaine — 2 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New Mexico

Full comparison — all codes billed, vs. state median

45 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	8	10	9,400	$40	$469.6K
J0897	5	50	3,150	$20	$113.2K
J1569	2	10	1,430	$40	$51.3K
G6015	7	10	70	$260	$49.4K
J0881	4	10	12,320	$1	$31.2K
J9217	12	20	180	$130	$23.4K
J1439	9	10	25,500	$1	$23.1K
96413	9	40	170	$90	$17.7K
99214	594	2,700	90	$70	$12.9K
J9041	2	10	2,190	$1	$10.7K

Showing 1–10 of 45

Related Providers

Other providers that share a Tax Identification Number (TIN) with Annette Fontaine, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
New Mexico Oncology Hematology Consultants, Ltd.	NM	Hematology & Oncology Physician	$0	$4.2M
Gregg Franklin	NM	Radiation Oncology Physician	$2.5M	$0
Scott Stoerner	NM	Rheumatology Physician	$1.5M	$0
Shaya Ansari	NY	Diagnostic Radiology Physician	$1.5M	$1K
Pranshu Bansal	AZ	Hematology & Oncology Physician	$1.4M	$0
Ronald Kubica	NM	Medical Oncology Physician	$1M	$0
Mrunal Tailor	NM	Diagnostic Radiology Physician	$897.5K	$0
Jose Avitia	NM	Hematology & Oncology Physician	$880.2K	$0
Amyn Alidina	NM	Medical Oncology Physician	$785K	$0
Masoud Shiehmorteza	NM	Diagnostic Radiology Physician	$773.7K	$0

Nearby Providers

Other providers in the same ZIP code as Annette Fontaine, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Presbyterian Healthcare Services	NM	Internal Medicine Physician	$0	$240.8M
Heritage Home Healthcare Services, Inc.	NM	Home Health Agency	$0	$141.5M
Home Medical Equipment Specialists LLC	NM	Durable Medical Equipment & Medical Supplies	$0	$100M
The New Beginnings LLC	NM	Adult Day Care Clinic/Center	$0	$85.1M
We Care Agency, Inc.	NM	In Home Supportive Care Agency	$0	$60.1M
Lovelace Health System, LLC	NM	General Acute Care Hospital	$0	$57.7M
Adelante Development Center, Inc.	NM	Personal Care Attendant	$0	$57M
Eye Associates Of New Mexico Ltd	NM	Ophthalmology Physician	$0	$46.9M
Southwest Labs LLC	NM	Clinical Medical Laboratory	$1.1M	$41.5M
Southwest Medical Associates, LLC	NM	General Practice Physician	$0	$41.4M

Annette Fontaine — Billing Profile & Reimbursement Data

Sign up for Annette Fontaine — Billing Profile & Reimbursement Data policy alerts

Annette Fontaine — Billing Profile & Reimbursement Data

Sign up for Annette Fontaine — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References